Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Micrococcus infection in patients receiving epoprostenol by continuous infusion.

× No keyword cloud information.

8 in total

1. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors: T E Kiehn; D Armstrong
Journal: Eur J Clin Microbiol Infect Dis Date: 1990-12 Impact factor: 3.267

2. Micrococcus luteus as a cause of recurrent bacteremia.

Authors: C von Eiff; N Kuhn; M Herrmann; S Weber; G Peters
Journal: Pediatr Infect Dis J Date: 1996-08 Impact factor: 2.129

3. Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia.

Authors: A Salar; J Carratalà; A Fernández-Sevilla; D Marín; A Grañena
Journal: Eur J Clin Microbiol Infect Dis Date: 1997-07 Impact factor: 3.267

Review 4. Defining intravascular catheter-related infections: a plea for uniformity.

Authors: L A Mermel
Journal: Nutrition Date: 1997-04 Impact factor: 4.008

5. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Authors: D B Badesch; V F Tapson; M D McGoon; B H Brundage; L J Rubin; F M Wigley; S Rich; R J Barst; P S Barrett; K M Kral; M M Jöbsis; J E Loyd; S Murali; A Frost; R Girgis; R C Bourge; D D Ralph; C G Elliott; N S Hill; D Langleben; R J Schilz; V V McLaughlin; I M Robbins; B M Groves; S Shapiro; T A Medsger
Journal: Ann Intern Med Date: 2000-03-21 Impact factor: 25.391

6. Microbial flora on the hands of health care personnel: differences in composition and antibacterial resistance.

Authors: W A Horn; E L Larson; K J McGinley; J J Leyden
Journal: Infect Control Hosp Epidemiol Date: 1988-05 Impact factor: 3.254

7. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

Authors: V V McLaughlin; D E Genthner; M M Panella; S Rich
Journal: N Engl J Med Date: 1998-01-29 Impact factor: 91.245

8. A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors: D G Maki; C E Weise; H W Sarafin
Journal: N Engl J Med Date: 1977-06-09 Impact factor: 91.245

8 in total

5 in total

Review 1. Prostacyclin for pulmonary hypertension in adults.

Authors: N S Paramothayan; T J Lasserson; A U Wells; E H Walters
Journal: Cochrane Database Syst Rev Date: 2005-04-18

2. Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.

Authors: D Sammut; C A Elliot; D G Kiely; I J Armstrong; L Martin; J Wilkinson; P Sephton; J Jones; N Hamilton; J Hurdman; E McLellan; I Sabroe; R Condliffe
Journal: Eur J Clin Microbiol Infect Dis Date: 2013-02-07 Impact factor: 3.267

3. Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.

Authors: Natalie Kitterman; Abby Poms; Dave P Miller; Sandra Lombardi; Harrison W Farber; Robyn J Barst
Journal: Mayo Clin Proc Date: 2012-08-09 Impact factor: 7.616

4. Kocuria kristinae infection associated with acute cholecystitis.

Authors: Edmond S K Ma; Chris L P Wong; Kristi T W Lai; Edmond C H Chan; W C Yam; Angus C W Chan
Journal: BMC Infect Dis Date: 2005-07-19 Impact factor: 3.090

5. Synergistic In Vitro Antimicrobial Activity of Pomegranate Rind Extract and Zinc (II) against Micrococcus luteus under Planktonic and Biofilm Conditions.

Authors: Vildan Celiksoy; Rachael L Moses; Alastair J Sloan; Ryan Moseley; Charles M Heard
Journal: Pharmaceutics Date: 2021-06-08 Impact factor: 6.321

5 in total